RAY B Stock Overview
A medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
RaySearch Laboratories AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 164.40 |
| 52 Week High | SEK 168.40 |
| 52 Week Low | SEK 78.40 |
| Beta | 1.34 |
| 11 Month Change | 25.30% |
| 3 Month Change | 13.38% |
| 1 Year Change | 100.73% |
| 33 Year Change | 163.04% |
| 5 Year Change | 0.55% |
| Change since IPO | 28,912.11% |
Recent News & Updates
Recent updates
RaySearch Laboratories AB (publ) (STO:RAY B) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
May 21
The Returns At RaySearch Laboratories (STO:RAY B) Aren't Growing
May 11RaySearch Laboratories (STO:RAY B) Will Want To Turn Around Its Return Trends
Oct 04Does RaySearch Laboratories (STO:RAY B) Have A Healthy Balance Sheet?
Jul 10Is RaySearch Laboratories (STO:RAY B) Using Too Much Debt?
Nov 17One Forecaster Is Now More Bearish On RaySearch Laboratories AB (publ) (STO:RAY B) Than They Used To Be
Mar 15Is RaySearch Laboratories (STO:RAY B) A Risky Investment?
Feb 22Is RaySearch Laboratories (STO:RAY B) Using Debt In A Risky Way?
Nov 04Is RaySearch Laboratories (STO:RAY B) Using Debt In A Risky Way?
Mar 30Shareholder Returns
| RAY B | SE Healthcare Services | SE Market | |
|---|---|---|---|
| 7D | 9.0% | 9.2% | -1.0% |
| 1Y | 100.7% | 66.0% | 18.6% |
Return vs Industry: RAY B exceeded the Swedish Healthcare Services industry which returned 60.3% over the past year.
Return vs Market: RAY B exceeded the Swedish Market which returned 18.7% over the past year.
Price Volatility
| RAY B volatility | |
|---|---|
| RAY B Average Weekly Movement | 7.1% |
| Healthcare Services Industry Average Movement | 5.3% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: RAY B has not had significant price volatility in the past 3 months.
Volatility Over Time: RAY B's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 411 | Johan Lof | www.raysearchlabs.com |
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research.
RaySearch Laboratories AB (publ) Fundamentals Summary
| RAY B fundamental statistics | |
|---|---|
| Market cap | SEK 5.64b |
| Earnings (TTM) | SEK 151.22m |
| Revenue (TTM) | SEK 1.13b |
37.3x
P/E Ratio5.0x
P/S RatioIs RAY B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RAY B income statement (TTM) | |
|---|---|
| Revenue | SEK 1.13b |
| Cost of Revenue | SEK 107.48m |
| Gross Profit | SEK 1.02b |
| Other Expenses | SEK 869.89m |
| Earnings | SEK 151.22m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 08, 2024
| Earnings per share (EPS) | 4.41 |
| Gross Margin | 90.48% |
| Net Profit Margin | 13.40% |
| Debt/Equity Ratio | 0% |
How did RAY B perform over the long term?
See historical performance and comparison